STAT3 is constitutively activated in multiple cancer types, such as HNSCC, breast cancer, lymphoma, melanoma, prostate cancer, and lung cancer, and plays an important role in tumorigenesis, progression, metastasis, and recurrence, resulting in poor clinical prognosis. This evidence concerns the gene STAT3 and cancer.